|
LOC100271831 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63813407283442E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25039999998577E-06 |
| Normal-vs-Stage2 |
2.022500E-02 |
| Normal-vs-Stage3 |
4.41099999859418E-08 |
| Normal-vs-Stage4 |
1.562950E-04 |
| Stage1-vs-Stage2 |
2.703600E-01 |
| Stage1-vs-Stage3 |
1.359590E-02 |
| Stage1-vs-Stage4 |
5.920500E-02 |
| Stage2-vs-Stage3 |
9.495200E-01 |
| Stage2-vs-Stage4 |
8.972400E-01 |
| Stage3-vs-Stage4 |
9.121600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26489954463705E-11 |
| Normal-vs-AfricanAmerican |
1.67127999999295E-05 |
| Normal-vs-Asian |
4.202200E-01 |
| Caucasian-vs-AfricanAmerican |
5.275200E-03 |
| Caucasian-vs-Asian |
8.400800E-01 |
| AfricanAmerican-vs-Asian |
3.609400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.01909658068689E-11 |
| Normal-vs-Female |
2.69750000003732E-07 |
| Male-vs-Female |
2.404200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.119500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.62930000286488E-08 |
| Normal-vs-Age(61-80Yrs) |
1.79250000398312E-08 |
| Normal-vs-Age(81-100Yrs) |
7.846100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.588400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.371800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.856400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.781000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.115400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.786200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.676320E-02 |
| Normal-vs-Grade 2 |
3.7915000000055E-05 |
| Normal-vs-Grade 3 |
3.4456999475907E-09 |
| Normal-vs-Grade 4 |
8.46970000000224E-05 |
| Grade 1-vs-Grade 2 |
6.188400E-01 |
| Grade 1-vs-Grade 3 |
8.465000E-01 |
| Grade 1-vs-Grade 4 |
4.549200E-01 |
| Grade 2-vs-Grade 3 |
2.602400E-01 |
| Grade 2-vs-Grade 4 |
1.199590E-01 |
| Grade 3-vs-Grade 4 |
4.014800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.239900E-02 |
| Normal-vs-ccB subtype |
3.49539999999759E-06 |
| ccA subtype-vs-ccB subtype |
4.415900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.01940000463952E-08 |
| Normal-vs-N1 |
1.481020E-01 |
| N0-vs-N1 |
8.030000E-01 |
|
|
